The impact of cisplat based chemotherapy on advanced ovarian cancer.
No Thumbnail Available
Date
1995-10-01
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Cisplatinum based chemotherapy has become the standard treatment for ovarian cancers due to its proved superiority over non-cisplat based regimes. However, the therapeutic impact of cisplat based regimes compared to cheaper non-cisplatinum based regimes is questionable when multiple variables such as residual disease, histologic type, grade are introduced. This report is a study of 110 Stage III ovarian cancer patients from 1985-89, with cisplat (n = 69) and non cisplat (n = 41) based chemotherapy. The results of both regimes with reference to the multiple variable factors are presented. We conclude that cisplat based regimes appear to be superior to non-cisplat based regimes except probably in poorly differentiated ovarian tumors where the results were similar with either regimen.
Description
Keywords
Citation
Prasad GR, Dalal AV, Tongaonkar HB, Chatterjee S, Kamat MR. The impact of cisplat based chemotherapy on advanced ovarian cancer. Journal of Postgraduate Medicine. 1995 Oct-Dec; 41(4): 95-8